Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days | Zendy

Helena Kopp Kallner | Zendy; Christian Fiala | Zendy; Olof Stephansson | Zendy; Kristina GemzellDanielsson | Zendy

Open Access

Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days

Author(s) -

Helena Kopp Kallner,

Christian Fiala,

Olof Stephansson,

Kristina GemzellDanielsson

Publication year - 2010

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/deq037

Subject(s) - misoprostol , gestation , medical abortion , obstetrics , medicine , abortion , products of conception , gynecology , intravaginal administration , pregnancy , mifepristone , vagina , biology , surgery , genetics

Home use of misoprostol for termination of pregnancy is still controversial in many countries. Acceptability of home use of misoprostol has been investigated in pregnancies below 49 days gestation. In this study, we aimed to assess efficacy, feasibility and acceptability of home use of vaginal misoprostol for medical termination of pregnancy at 50-63 days compared with gestation of below 50 days among women who chose to administer misoprostol at home.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research